The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

Zaknun, J.; Bodei, L.; Mueller‐Brand, J.; Pavel, Marianne; Baum, R.; Hörsch, Dieter; O'dorisio, M.; M. O’Dorisiol, T.; Howe, J.; Cremonesi, M.; Kwekkeboom, D.

doi:10.1007/s00259-012-2330-6

Public

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

Shared by NobleBlocks on Feb 7, 2013 • 12:00 AM UTC

Authors:

J. Zaknun

L. Bodei

J. Mueller‐Brand

Abstract

Peptide receptor radionuclide therapy (PRRNT) is a molecularly targeted radiation therapy involving the systemic administration of a radiolabelled peptide designed to target with high affinity and specificity receptors overexpressed on tumours. PRRNT employing the radiotagged somatostatin receptor a...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!